Healthcare -
Biotechnology - NASDAQ - US
$ 5.5
5.16 %
$ 49 M
Market Cap
-11.22
P/E
ICCC - OPERATING INCOME
Operating Income ICCC - ImmuCell Corporation
-5.75 M
LAST VALUE
-61.49%
2 YEAR CAGR
-31.77%
5 YEAR CAGR
-76.54%
10 YEAR CAGR